FACTOR XIII CONCENTRATE: 155 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
155
Total FAERS Reports
9 (5.8%)
Deaths Reported
32
Hospitalizations
155
As Primary/Secondary Suspect
14
Life-Threatening
5
Disabilities
First Report: 19940912 · Latest Report: 20250710
What Are the Most Common FACTOR XIII CONCENTRATE Side Effects?
#1 Most Reported
Drug ineffective
25 reports (16.1%)
#2 Most Reported
No adverse event
20 reports (12.9%)
#3 Most Reported
Haemorrhage
12 reports (7.7%)
All FACTOR XIII CONCENTRATE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 25 | 16.1% | 4 | 6 |
| No adverse event | 20 | 12.9% | 0 | 0 |
| Haemorrhage | 12 | 7.7% | 1 | 1 |
| Device issue | 9 | 5.8% | 0 | 0 |
| Off label use | 8 | 5.2% | 0 | 2 |
| Product preparation issue | 8 | 5.2% | 0 | 0 |
| Product use in unapproved indication | 8 | 5.2% | 1 | 0 |
| Abortion spontaneous | 7 | 4.5% | 0 | 0 |
| Exposure during pregnancy | 7 | 4.5% | 0 | 3 |
| Factor xiii inhibition | 7 | 4.5% | 0 | 2 |
| Deep vein thrombosis | 5 | 3.2% | 0 | 1 |
| Drug ineffective for unapproved indication | 5 | 3.2% | 0 | 0 |
| Dyspnoea | 5 | 3.2% | 0 | 3 |
| Epistaxis | 5 | 3.2% | 0 | 0 |
| Hypersensitivity | 5 | 3.2% | 0 | 1 |
Who Reports FACTOR XIII CONCENTRATE Side Effects? Age & Gender Data
Gender: 65.2% female, 34.8% male. Average age: 38.2 years. Most reports from: US. View detailed demographics →
Is FACTOR XIII CONCENTRATE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2001 | 1 | 0 | 0 |
| 2009 | 3 | 0 | 0 |
| 2010 | 4 | 0 | 3 |
| 2012 | 1 | 0 | 1 |
| 2013 | 2 | 0 | 0 |
| 2014 | 2 | 0 | 0 |
| 2015 | 9 | 0 | 4 |
| 2016 | 3 | 0 | 1 |
| 2017 | 1 | 0 | 0 |
| 2018 | 5 | 1 | 2 |
| 2019 | 10 | 0 | 1 |
| 2020 | 3 | 0 | 1 |
| 2021 | 4 | 0 | 1 |
| 2022 | 4 | 0 | 1 |
| 2023 | 5 | 0 | 0 |
| 2024 | 6 | 0 | 4 |
| 2025 | 2 | 0 | 1 |
What Is FACTOR XIII CONCENTRATE Used For?
| Indication | Reports |
|---|---|
| Factor xiii deficiency | 57 |
| Product used for unknown indication | 19 |
| Prophylaxis | 18 |
| Coagulation factor deficiency | 9 |
| Haemorrhage | 6 |
| Abnormal clotting factor | 5 |
| Haemorrhage prophylaxis | 5 |
FACTOR XIII CONCENTRATE vs Alternatives: Which Is Safer?
FACTOR XIII CONCENTRATE vs FAM-TRASTUZUMAB DERUXTECAN-NXKI
FACTOR XIII CONCENTRATE vs FAMCICLOVIR
FACTOR XIII CONCENTRATE vs FAMOTIDINE
FACTOR XIII CONCENTRATE vs FAMOTIDINE\IBUPROFEN
FACTOR XIII CONCENTRATE vs FARICIMAB
FACTOR XIII CONCENTRATE vs FARICIMAB-SVOA
FACTOR XIII CONCENTRATE vs FARICIMAB\FARICIMAB-SVOA
FACTOR XIII CONCENTRATE vs FASLODEX
FACTOR XIII CONCENTRATE vs FAVIPIRAVIR
FACTOR XIII CONCENTRATE vs FEBUXOSTAT
Official FDA Label for FACTOR XIII CONCENTRATE
Official prescribing information from the FDA-approved drug label.